Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population
Authors:
- Yoon Young ChoYCYoon Young Cho
- So Young ParkSPSo Young Park
- Jung Hee ShinJSJung Hee Shin
- Young Lyun OhYOYoung Lyun Oh
- Jun-Ho ChoeJCJun-Ho Choe
- Jung-Han KimJKJung-Han Kim
- Jee Soo KimJKJee Soo Kim
- Hyun Sook YimHYHyun Sook Yim
- Yoo-Li KimYKYoo-Li Kim
- Chang-Seok KiCKChang-Seok Ki
- Tae Hyuk KimTKTae Hyuk Kim
- Jae Hoon ChungJCJae Hoon Chung
Open Access
- 6 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5629
Abstract
Molecular testing offers more objective information in the diagnosis and personalized decision making for thyroid nodules. In Korea, as the BRAF V600E mutation is detected in 70–80% of thyroid cancer specimens, its testing in fine-needle aspiration (FNA) cytology specimens alone has been used for the differential diagnosis of thyroid nodules until now. Thus, we aimed to develop a mutation panel to detect not only BRAF V600E, but also other common genetic alterations in thyroid cancer and to evaluate the diagnostic accuracy of the mutation panel for thyroid nodules in Korea. For this prospective study, FNA specimens of 430 nodules were obtained from patients who underwent thyroid surgery for thyroid nodules. A molecular test was devised using real-time PCR to detect common genetic alterations in thyroid cancer, including BRAF, N-, H-, and K-RAS mutations and rearrangements of RET/PTC and PAX8/PPARr. Positive results for the mutation panel were confirmed by sequencing. Among the 430 FNA specimens, genetic alterations were detected in 293 cases (68%). BRAF V600E (240 of 347 cases, 69%) was the most prevalent mutation in thyroid cancer. The RAS mutation was most prevalently detected for indeterminate cytology. Among the 293 mutation-positive cases, 287 (98%) were diagnosed as cancer. The combination of molecular testing and cytology improved sensitivity from 72% (cytology alone) to 89% (combination), with a specificity of 93%. We verified the excellent diagnostic performance of the mutation panel applicable for clinical practice in Korea. A plan has been devised to validate its performance using independent FNA specimens.Keywords
Funding Information
- Samsung Biomedical Research Institute (CRO113031)
This publication has 28 references indexed in Scilit:
- The 2017 Bethesda System for Reporting Thyroid CytopathologyThyroid®, 2017
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Diagnostic value of fine needle aspiration BRAFV600E mutation analysis in papillary thyroid cancer: a systematic review and meta-analysisHuman Pathology, 2015
- Centralized Molecular Testing for Oncogenic Gene Mutations Complements the Local Cytopathologic Diagnosis of Thyroid NodulesThyroid®, 2014
- Faculty Opinions recommendation of High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.2013
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA SamplesThe Journal of Clinical Endocrinology & Metabolism, 2011
- Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of CytologyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examinationEuropean Journal of Clinical Investigation, 2009
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid NodulesThe Journal of Clinical Endocrinology & Metabolism, 2009
- Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid ImagingAnnals of Internal Medicine, 1997